OX2 Therapeutics jobs and careers
Minneapolis, MN, United States
About OX2 Therapeutics
OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors. Its novel CD200 Checkpoint peptide inhibitor activates the immune system through a CD200 activation receptor, enabling healthcare institutes to apply receptor antibodies that permit the immune system army to pass through blood vessel walls and kill canceractivities.
Founded in 2016 by Christopher Moertel and Sumant Dhawan.
- Founded
- 2016
- Employees
- 1 to 10
- Total funding
- $649K
- Headquarters
- Minneapolis
Jobs at OX2 Therapeutics
No open positions right now. Explore more companies on TheJobsMap.